Skip to main content
. 2026 May 19;14(5):1147. doi: 10.3390/biomedicines14051147
ALT Alanine aminotransferase
AST Aspartate aminotransferase
CAP Controlled attenuation parameter
CKD Chronic kidney disease
FIB-4 Fibrosis-4 Index
LPS Lipopolysaccharide
MAFLD Metabolic dysfunction-associated fatty liver disease
MASLD Metabolic dysfunction-associated steatotic liver disease
MASH Metabolic dysfunction-associated steatohepatitis
MetALD Metabolic alcohol-related liver disease
MRE Magnetic resonance elastography
MRI-PDFF Magnetic resonance imaging-proton density fat fraction
NAFLD Non-alcoholic fatty liver disease
NASH Non-alcoholic steatohepatitis
NFS NAFLD Fibrosis Score
T2DM Type 2 diabetes mellitus
VCTE Vibration-controlled transient elastography
TNF-α Tumor necrosis factor-alpha
IL-6 Interleukin-6
TLR4/NF-κB Toll-like receptor 4/nuclear factor-kappa B
AMPK AMP-activated protein kinase
ROS Reactive oxygen species
STK39 Serine-threonine kinase 39